Pulmonary Alveolar Hemorrhage: Causes, Treatment, and Management

Introduction to Pulmonary Alveolar Hemorrhage

ANCA-associated vasculitis accounts for approximately 25% of cases presenting with diffuse alveolar hemorrhage, making it the leading autoimmune cause 1
Anti-glomerular basement membrane (anti-GBM) disease causes pulmonary-renal syndrome with DAH; delayed treatment results in 96% mortality 1

Mechanical ventilation itself can cause pulmonary hemorrhage in 26 of 69 ventilated patients in one autopsy series, sometimes coexisting with pneumonia 2
Pulmonary embolism with infarction: alveolar hemorrhage occurs due to obstruction of distal pulmonary arteries with influx of bronchial arterial blood, though progression to true infarction is uncommon except in patients with pre-existing heart failure or pulmonary disease 3

Noninfectious mimics: atelectasis, congestive heart failure, pulmonary embolus, lung contusion, chemical pneumonitis from aspiration, and ARDS with fibroproliferative diffuse alveolar damage can all be mistaken for pneumonia or DAH 2

For DAH with hypoxemia, immediately initiate high-dose intravenous glucocorticoids plus either rituximab (preferred) or cyclophosphamide without waiting for diagnostic confirmation, as delayed treatment dramatically worsens outcomes 1, 4
Glucocorticoid dosing: IV methylprednisolone 500-1000 mg/day for 3 consecutive days (maximum cumulative dose 3 grams) 1, 4
Transition to weight-based oral prednisone: <50 kg = 50 mg/day; 50-75 kg = 60 mg/day; >75 kg = 75 mg/day 1
Taper to reach 5 mg/day by weeks 19-52 1
Rituximab is preferred over cyclophosphamide when combined with glucocorticoids for remission induction 4
Continue maintenance immunosuppression for 18 months to 4 years after remission to prevent relapse in ANCA-associated vasculitis 1, 4

Use lung-protective ventilation: tidal volumes 6-8 mL/kg predicted body weight 1, 4
Maintain plateau pressure ≤30 cmH₂O 1, 4
Apply moderate PEEP (6-8 cmH₂O) to maintain oxygenation while avoiding high recruitment pressures 1
Avoid aggressive recruitment maneuvers as continuous positive airway pressure at 35 cmH₂O can increase intracranial pressure and decrease cerebral perfusion 1

Consider plasma exchange for DAH with hypoxemia when: serum creatinine >3.4 mg/dL (>300 μmol/L) 1, 4
Patient requires dialysis 1, 4
Concomitant anti-GBM disease present 1, 4

Track PaO₂/FiO₂ ratio improvement as primary oxygenation parameter 1, 4
Serial chest imaging for resolution of ground-glass opacities and consolidation 1, 4
Clinical symptoms including dyspnea and hemoptysis (though mortality risk correlates more with rate of hemoptysis than quantity) 1, 4

High mortality risk factors in ANCA-associated vasculitis with DAH: older age 1
Severe kidney failure 1
Degree of hypoxemia 1
Involvement of >50% of lung area 1
Infection is the leading cause of death (48%) within the first year in microscopic polyangiitis patients, emphasizing the need to balance aggressive immunosuppression against infection risk 1